Adial Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is…

Biotechnology
US, Charlottesville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Adial Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Adial Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Adial Pharmaceuticals, Inc..

End of ADIL's Analysis
CIK: 1513525 CUSIP: 00688A106 ISIN: US00688A2050 LEI: - UEI: -
Secondary Listings
ADIL has no secondary listings inside our databases.